Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

Identification of new SNPs associated with severe toxicity to capecitabine.

Pellicer M, García-González X, García MI, Robles L, Grávalos C, García-Alfonso P, Pachón V, Longo F, Martínez V, Blanco C, Iglesias I, Sanjurjo M, López-Fernández LA.

Pharmacol Res. 2017 Jun;120:133-137. doi: 10.1016/j.phrs.2017.03.021. Epub 2017 Mar 27.

PMID:
28347776
2.

[Rethinking the Ottawa Charter 30 years later].

López-Fernández LA, Solar Hormazábal O.

Gac Sanit. 2017 Feb 22. pii: S0213-9111(17)30042-0. doi: 10.1016/j.gaceta.2016.12.013. [Epub ahead of print] Spanish. No abstract available.

3.

Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkers.

De Andres C, García MI, Goicoechea H, Martínez-Ginés ML, García-Domínguez JM, Martín ML, Romero-Delgado F, Benguría A, Sanjurjo M, López-Fernández LA.

Pharmacogenomics J. 2016 Sep 27. doi: 10.1038/tpj.2016.71. [Epub ahead of print]

PMID:
27670768
4.

Cost-effectiveness of screening for DPYD polymorphisms to prevent neutropenia in cancer patients treated with fluoropyrimidines.

Cortejoso L, García-González X, García MI, García-Alfonso P, Sanjurjo M, López-Fernández LA.

Pharmacogenomics. 2016 Jun;17(9):979-84. doi: 10.2217/pgs-2016-0006. Epub 2016 Jun 1.

PMID:
27248859
5.

Gender inequalities in COPD decision-making in primary care.

Delgado A, Saletti-Cuesta L, López-Fernández LA, Gil-Garrido N, Luna Del Castillo Jde D.

Respir Med. 2016 May;114:91-6. doi: 10.1016/j.rmed.2016.03.017. Epub 2016 Mar 25.

PMID:
27109817
6.

Was access to health care easy for immigrants in Spain? The perspectives of health personnel in Catalonia and Andalusia.

Vázquez ML, Vargas I, Jaramillo DL, Porthé V, López-Fernández LA, Vargas H, Bosch L, Hernández SS, Azarola AR.

Health Policy. 2016 Apr;120(4):396-405. doi: 10.1016/j.healthpol.2016.01.011. Epub 2016 Jan 18.

PMID:
26898401
7.

Clinical implementation of pharmacogenetics.

García-González X, Cabaleiro T, Herrero MJ, McLeod H, López-Fernández LA.

Drug Metab Pers Ther. 2016 Mar;31(1):9-16. doi: 10.1515/dmpt-2015-0031. Review.

8.

Ammonia Affects Astroglial Proliferation in Culture.

Bodega G, Segura B, Ciordia S, Mena Mdel C, López-Fernández LA, García MI, Trabado I, Suárez I.

PLoS One. 2015 Sep 30;10(9):e0139619. doi: 10.1371/journal.pone.0139619. eCollection 2015.

9.

Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer.

García-González X, Cortejoso L, García MI, García-Alfonso P, Robles L, Grávalos C, González-Haba E, Marta P, Sanjurjo M, López-Fernández LA.

Oncotarget. 2015 Mar 20;6(8):6422-30.

10.

[Validation of genetic polymorphisms associated to the toxicity of chemotherapy in colorectal cancer patients].

Cortejoso L, García MI, García-Alfonso P, Grávalos C, Robles L, González-Haba E, Sanjurjo M, López-Fernández LA.

Farm Hosp. 2014 Jul 1;38(4):283-90. doi: 10.7399/fh.2014.38.4.1121. Spanish.

11.

Professional Success and Gender in Family Medicine: Design of Scales and Examination of Gender Differences in Subjective and Objective Success Among Family Physicians.

Delgado A, Saletti-Cuesta L, López-Fernández LA, Toro-Cárdenas S, Luna del Castillo Jde D.

Eval Health Prof. 2016 Mar;39(1):87-99. doi: 10.1177/0163278714543686. Epub 2014 Jul 21.

PMID:
25049366
12.

Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses.

Wheeler HE, González-Neira A, Pita G, de la Torre-Montero JC, Alonso R, Lopez-Fernandez LA, Alba E, Martín M, Dolan ME.

Pharmacogenet Genomics. 2014 May;24(5):231-7. doi: 10.1097/FPC.0000000000000037.

13.

A genome-wide association study on copy-number variation identifies a 11q11 loss as a candidate susceptibility variant for colorectal cancer.

Fernandez-Rozadilla C, Cazier JB, Tomlinson I, Brea-Fernández A, Lamas MJ, Baiget M, López-Fernández LA, Clofent J, Bujanda L, Gonzalez D, de Castro L; EPICOLON Consortium, Hemminki K, Bessa X, Andreu M, Jover R, Xicola R, Llor X, Moreno V, Castells A, Castellví-Bel S, Carracedo A, Ruiz-Ponte C.

Hum Genet. 2014 May;133(5):525-34. doi: 10.1007/s00439-013-1390-4. Epub 2013 Nov 12.

PMID:
24218287
14.

[Gender differences in the perception of professional achievement in family medicine, Spain].

Saletti-Cuesta L, Delgado A, Ortiz-Gómez T, López-Fernández LA.

Rev Esp Salud Publica. 2013 May-Jun;87(3):221-38. doi: 10.4321/S1135-57272013000300002. Spanish.

15.

Estradiol downregulates NF-κb translocation by Ikbkg transcriptional repression in dendritic cells.

Lasarte S, Elsner D, Sanchez-Elsner T, Fernandez-Pineda A, López-Fernández LA, Corbí AL, Muñoz-Fernandez MA, Relloso M.

Genes Immun. 2013 Oct;14(7):462-9. doi: 10.1038/gene.2013.35. Epub 2013 Jul 25.

PMID:
23883819
16.

Endocrine disruptors, gene deregulation and male germ cell tumors.

Del-Mazo J, Brieño-Enríquez MA, García-López J, López-Fernández LA, De-Felici M.

Int J Dev Biol. 2013;57(2-4):225-39. doi: 10.1387/ijdb.130042jd. Review.

17.

Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer.

Cortejoso L, García MI, García-Alfonso P, González-Haba E, Escolar F, Sanjurjo M, López-Fernández LA.

Cancer Chemother Pharmacol. 2013 Jun;71(6):1463-72. doi: 10.1007/s00280-013-2145-6. Epub 2013 Mar 31. Erratum in: Cancer Chemother Pharmacol. 2013 Aug;72(2):491.

PMID:
23543295
18.

[Familial characteristics and self-perceived health among female and male primary care physicians in Andalusia (Spain)].

Delgado A, Saletti-Cuesta L, López-Fernández LA, Toro-Cárdenas S.

Gac Sanit. 2013 Nov-Dec;27(6):508-15. doi: 10.1016/j.gaceta.2012.12.008. Epub 2013 Jan 29. Spanish.

19.

A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12.

Fernandez-Rozadilla C, Cazier JB, Tomlinson IP, Carvajal-Carmona LG, Palles C, Lamas MJ, Baiget M, López-Fernández LA, Brea-Fernández A, Abulí A, Bujanda L, Clofent J, Gonzalez D, Xicola R, Andreu M, Bessa X, Jover R, Llor X; EPICOLON Consortium, Moreno V, Castells A, Carracedo Á, Castellvi-Bel S, Ruiz-Ponte C.

BMC Genomics. 2013 Jan 26;14:55. doi: 10.1186/1471-2164-14-55.

20.

Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients.

Rallon NI, Lopez-Fernandez LA, Garcia MI, Benguria A, Fiorante S, Soriano V, Benito JM.

AIDS. 2013 Mar 13;27(5):687-96. doi: 10.1097/QAD.0b013e32835ce2c1.

PMID:
23196939

Supplemental Content

Loading ...
Support Center